Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lilium Otsuka is a Japanese medical technology company specializing in urological healthcare solutions, operating as a subsidiary of Otsuka Pharmaceutical Factory. The company focuses on the development of non-invasive ultrasound devices designed to monitor bladder volume, such as the Lilium-α200 and Lilium-spot. These devices assist patients and healthcare providers in managing urinary dysfunction, including neurogenic bladder and urinary incontinence, by providing real-time data on bladder fullness. By facilitating optimal timing for catheterization and toilet training, Lilium Otsuka's products aim to reduce the risk of urinary tract infections and improve the quality of life for patients. The company’s technology represents a significant advancement in the integration of sensory diagnostics within clinical and home care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lilium Otsuka.